banner
Franchise News

Cannabis Stocks Falter as FDA Shares Conflicting Views on CBD After Regulatory Hearing

The fate of recent wellness rockstar, CBD—a cannabis derivative—remains unknown as the FDA debates regulation amidst growing public demand.

By Katie LaTourStaff Writer
2:09 PM • 06/05/19

MORE STORIES LIKE THIS

iconBuy A Franchise